Cardiac glial cells release neurotrophic S100B upon catheter-based treatment of atrial fibrillation
Standard
Cardiac glial cells release neurotrophic S100B upon catheter-based treatment of atrial fibrillation. / Scherschel, Katharina; Hedenus, Katja; Jungen, Christiane; Lemoine, Marc D; Rübsamen, Nicole; Veldkamp, Marieke W; Klatt, Niklas; Lindner, Diana; Westermann, Dirk; Casini, Simona; Kuklik, Pawel; Eickholt, Christian; Klöcker, Nikolaj; Shivkumar, Kalyanam; Christ, Torsten; Zeller, Tanja; Willems, Stephan; Meyer, Christian.
In: SCI TRANSL MED, Vol. 11, No. 493, 22.05.2019.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Cardiac glial cells release neurotrophic S100B upon catheter-based treatment of atrial fibrillation
AU - Scherschel, Katharina
AU - Hedenus, Katja
AU - Jungen, Christiane
AU - Lemoine, Marc D
AU - Rübsamen, Nicole
AU - Veldkamp, Marieke W
AU - Klatt, Niklas
AU - Lindner, Diana
AU - Westermann, Dirk
AU - Casini, Simona
AU - Kuklik, Pawel
AU - Eickholt, Christian
AU - Klöcker, Nikolaj
AU - Shivkumar, Kalyanam
AU - Christ, Torsten
AU - Zeller, Tanja
AU - Willems, Stephan
AU - Meyer, Christian
N1 - Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
PY - 2019/5/22
Y1 - 2019/5/22
N2 - Atrial fibrillation (AF), the most common sustained heart rhythm disorder worldwide, is linked to dysfunction of the intrinsic cardiac autonomic nervous system (ICNS). The role of ICNS damage occurring during catheter-based treatment of AF, which is the therapy of choice for many patients, remains controversial. We show here that the neuronal injury marker S100B is expressed in cardiac glia throughout the ICNS and is released specifically upon catheter ablation of AF. Patients with higher S100B release were more likely to be AF free during follow-up. Subsequent in vitro studies revealed that murine intracardiac neurons react to S100B with diminished action potential firing and increased neurite growth. This suggests that release of S100B from cardiac glia upon catheter-based treatment of AF is a hallmark of acute neural damage that contributes to nerve sprouting and can be used to assess ICNS damage.
AB - Atrial fibrillation (AF), the most common sustained heart rhythm disorder worldwide, is linked to dysfunction of the intrinsic cardiac autonomic nervous system (ICNS). The role of ICNS damage occurring during catheter-based treatment of AF, which is the therapy of choice for many patients, remains controversial. We show here that the neuronal injury marker S100B is expressed in cardiac glia throughout the ICNS and is released specifically upon catheter ablation of AF. Patients with higher S100B release were more likely to be AF free during follow-up. Subsequent in vitro studies revealed that murine intracardiac neurons react to S100B with diminished action potential firing and increased neurite growth. This suggests that release of S100B from cardiac glia upon catheter-based treatment of AF is a hallmark of acute neural damage that contributes to nerve sprouting and can be used to assess ICNS damage.
U2 - 10.1126/scitranslmed.aav7770
DO - 10.1126/scitranslmed.aav7770
M3 - SCORING: Journal article
C2 - 31118294
VL - 11
JO - SCI TRANSL MED
JF - SCI TRANSL MED
SN - 1946-6234
IS - 493
ER -